Muscle expression of PD1 and PD-L1 may predict the severity and outcomes of neuromuscular immune-related adverse events caused by immune checkpoint inhibitor treatment.

Clin Rheumatol · 2026 · PMC12923435 · PMID 41454201

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

showed a trendP = 0.055so close (0.05 < p ≤ 0.1)

PD-L1 expression significantly correlated with serum CK levels ( r = 0.442, P = 0.038) and MMT-8 score ( r = − 0.415, P = 0.049), and showed a trend toward significant correlation with CTCAE grade ( r = 0.407, P = 0.055).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.